Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410389 | SCV000485532 | likely pathogenic | GNE myopathy | 2015-12-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003766120 | SCV004569762 | likely pathogenic | GNE myopathy; Sialuria | 2023-09-19 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GNE protein function. ClinVar contains an entry for this variant (Variation ID: 370270). This variant is also known as V421A. This missense change has been observed in individuals with autosomal recessive distal myopathy (PMID: 15136692, 23558691, 27829678). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 452 of the GNE protein (p.Val452Ala). |